Eli Lilly moves to stop proposed Alimta generic

26-01-2015

Eli Lilly moves to stop proposed Alimta generic

Susan Montgomery / Shutterstock.com

Eli Lilly has sued health care company Fresenius for allegedly infringing a patent covering its $2 billion-a-year lung cancer drug Alimta (pemetrexed).


Alimta, Eli Lilly, Fresenius, ANDA, cancer

LSIPR